Medication Administration Program (MAP) Recent News

Updates to the MAP website

12-11-2025

• MAP Stakeholder Workgroup Presentation 12/11/25 (PPTX) | (DOCX)

11-17-2025

• MAP Policy Manual 11/17/25 (PDF) | (DOCX)
• MAP Policy Manual, Guide to Updates and Changes 11/17/25 (PDF) | (DOCX)

11-10-2025

• State-Funded Electronic Medication Administration Record (eMAR) system (PDF) | (DOCX)

8-25-2025

• State Sponsored eMAR System Notice 8.25.25 (PDF) | (DOCX)

8-21-2025

A state sponsored eMAR for MAP providers

• Medication Administration Program(MAP) Stakeholder Workgroup Presentation 8.21.25 (PPTX) | (DOCX)

4-22-2025

The Medication Administration Program (MAP) Patient Prescribing Directives document has been updated and is located in MAP Resources

4-3-2024

The purpose of this advisory is to provide clarification and guidance applicable to the administration of medications to children residing at Approved Private Special Education School Residential Programs (ASERPs) jointly approved and licensed by the Department of Elementary and Secondary Education (DESE) and the Department of Early Education and Care (DEEC). This guidance does not apply to other types of residential or boarding schools.

• Medication Administration in Private Approved Special Education School Residential Programs (PDF) | (DOCX)

4-21-2023

• Circular Letter: DCP 23-04-119

MAP Evaluation Report 2022

• MAP Evaluation Report 2022 (PDF)
• MAP Evaluation Report 2022 (DOCX)
• MAP Evaluation Report 2022 Summary (PPT)

12-10-2021

Methadone – Storage and Administration of Take-Home Doses (PDF) | (DOC)

3-05-2020

Medication Administration in Private Approved Special Education School Residential Programs

Archived